Octopus Investments has led a £2 million investment into clinical trials platform TrialReach alongside Amadeus Capital Partners.
Cerus Endovascular is moving its operations to Liverpool Science Park following backing from The North West Fund for Biomedical.
Care home operator Springfield Healthcare Group has already begun to use its Business Growth Fund cash to get acquisitive. We find out how progress has been since the investment as part of an exclusive portfolio roundtable.
Neuropsychological testing business Cambridge Cognition has joined London's Alternative Investment Market.
Business Growth Fund portfolio company Springfield Homecare Services has closed its first acquisition since the business was supported by the bank-backed fund in June 2012.
The private equity firm behind investments in Wagamama and Paperchase has sold its stake in Optimum Care through a trade sale.
Two new investments for Mercia Fund Management has kicked off its Mercia Growth Fund 1 efforts.
A £5 million investment from Isis Equity Partners' Baronsmead VCTs will be used to aid the development of a new fertility clinic for Create Health.
Medical communications agency Fishawack has a new private equity backer through a secondary buy-out deal.
Scottish medical technologies company Taragenyx has secured itself £1.3 million of seed capital to speed up the development of its orthopaedic and dental implant coatings.
A £25 million fundraising for infirst HEALTHCARE will be used to launch the company's medicines into the US market.
A first joint venture hospital acquisition between the NHS and a private healthcare provider has resulted in the purchase of a mental health rehabilitation institution.
A £1 million investment from The North West Fund for Biomedical is set to be used by Diagnostic Healthcare to expand its portfolio of medical equipment.
Care UK has closed the acquisition of UK Specialist Hospitals to expand its resources and expertise.
Medical technology company Sapiens Steering Brain Stimulation has secured a further €7.5 million (£6.6 million) investment to add to the Series A funding it began in 2011.
Angel network Envestors has tapped into an investor pool in Monaco to secure backing for Cipher Surgical.
AIM-listed drug discovery and development company e-Therapeutics is to raise £40 million via an issue of shares to new and existing institutional backers.
Investment firm Albion Ventures has added MyMeds&Me to its portfolio through a £2 million transaction.
A £125,000 equity investment allocation has been secured by LumbaCurve International to aid in its efforts to conduct market development and a clinical effectiveness study for its lower back pain treatment.
An investment of €1 million (£854,000) is set to allow biotech business Algae Health to recruit an extra 23 people in the coming three years.
David Barker reflects on resisting the temptation to say 'Yes' to the first offer when he opened his data centre, and how choosing instead to diversify his client base at launch has enabled 4D Data Centres to maintain rapid growth in a recession.
Sophia Harrison, director of financial and professional services at Grayling, looks at how a new exchange platform out of Sweden could strike the right chord of regulation for SMEs.
That a team of 13 could build a business worth $1 billion should be the inspiration that all entrepreneurs need.
New research from GrowthBusiness shows that the number of UK cash shells is climbing. We speak to new entrants to the market and those that have recently closed deals to find out what’s driving shells’ increasing popularity.